Australia markets closed

Kuros Biosciences AG (CSBTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.58+0.08 (+1.07%)
At close: 09:30AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-11,142
-13,727
-14,595
-7,541
-11,520
Depreciation & amortisation
2,862
2,752
2,834
2,880
2,669
Stock-based compensation
233
917
1,030
389
752
Change in working capital
-5,717
-3,649
-1,397
-193
-730
Inventory
-935
-2,477
-1,585
-340
-516
Other working capital
-11,690
-9,170
-7,748
-5,833
-9,459
Other non-cash items
3,585
2,082
933
889
274
Net cash provided by operating activities
-11,478
-8,844
-7,348
-5,459
-9,239
Cash flows from investing activities
Investments in property, plant and equipment
-212
-326
-400
-374
-220
Net cash used for investing activities
-212
-326
-400
-374
-220
Net change in cash
-5,629
-9,341
-4,524
245
7,618
Cash at beginning of period
27,221
24,065
28,623
28,388
20,802
Cash at end of period
21,592
14,208
24,065
28,623
28,388
Free cash flow
Operating cash flow
-11,478
-8,844
-7,348
-5,459
-9,239
Capital expenditure
-212
-326
-400
-374
-220
Free cash flow
-11,690
-9,170
-7,748
-5,833
-9,459